Takeda and Endo hit with pay-for-delay claims

Alex Wilts

28 June 2021

Shutterstock/Michael Vi

Takeda Pharmaceutical and Endo International are facing a lawsuit over an alleged scheme to block generic competition to Takeda’s branded anti-constipation drug Amitiza.

Subscribe to Global Competition Review

Subscribe to unlock unlimited access

Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.

Subscribe now

Already have access? Login below

Alex Wilts

View full biography

Author | Editor, GCR USA

[email protected]

Tipline

The Rent is Too Damn High: The Tipline for 25 November 2022
The Department of Justice is reportedly probing whether real estate technology company RealPage is coordinating a price-fixing conspiracy on behalf of apartment complexes. Gone are the days of scouring for minutes of meetings in smoke-filled rooms – Section 1 cases will henceforth be found by scouring through lines of code, as if antitrust cases weren’t already complicated enough. Also in Tipline, a Microsoft/Activision Blizzard challenge looks increasingly likely and US Sugar responds to the …
Yes harm, yes fowl: The Tipline for 23 November 2022
Castles in the sky: The Tipline for 22 November 2022

Takeda and Endo hit with pay-for-delay claims

Subscribe to Global Competition Review

Subscribe to unlock unlimited access

Already have access? Login below

Related Topics

Alex Wilts